Notably, intranasal administration of another antimicrobial peptide, mCRAMP (murine orthologue of LL-37), triggered asthma exacerbation in an allergic asthma mouse model (53), hence suggesting a unique role of hBD-2 in this setting. Here, DEFB4A is linked to asthma.